Showing results (311-320 of 399) with videos related to
Sort By:
Pageof 40
Cancer|March 1, 1984
Mitomycin C intravesical therapy in noninvasive bladder cancer after failure on thiotepaB F Issell, G R Prout, M S Soloway, et al.Proceedings of the National Academy of Sciences of the United States of America|February 1, 1978
Inhibition of growth and guanylate cyclase activity of an undifferentiated prostate adenocarcinoma by an extract of the balsam pear (Momordica charantia abbreviata)A J Claflin, D L Vesely, J L Hudson, et al.Hormones & Cancer|March 11, 2015
Expression of Receptors for Pituitary-Type Growth Hormone-Releasing Hormone (pGHRH-R) in Human Papillary Thyroid Cancer Cells: Effects of GHRH Antagonists on Matrix Metalloproteinase-2Paola Catanuto, Jun Tashiro, Ferenc G Rick, et al.Cell Cycle (Georgetown, Tex.)|July 4, 2012
Combination of gastrin-releasing peptide antagonist with cytotoxic agents produces synergistic inhibition of growth of human experimental colon cancersFerenc G Rick, Stefan Buchholz, Andrew V Schally, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 18, 2000
MAG3-F0 scintigraphy in decision making for emergency intervention in renal colic after helical CT positive for a urolithG N Sfakianakis, D J Cohen, R H Braunstein, et al.The Pediatric Infectious Disease Journal|November 16, 2016
Lot-to-lot Consistency, Safety, Tolerability and Immunogenicity of an Investigational Hexavalent Vaccine in US InfantsStanley L Block, Nicola P Klein, Kwabena Sarpong, et al.Pediatrics|March 4, 2008
Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of ageTerry Nolan, David I Bernstein, Stan L Block, et al.Oncotarget|August 6, 2016
Agonistic analogs of growth hormone releasing hormone (GHRH) promote wound healing by stimulating the proliferation and survival of human dermal fibroblasts through ERK and AKT pathwaysTengjiao Cui, Joaquin J Jimenez, Norman L Block, et al.Cancer|November 15, 1996
A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate carcinoma. Analysis of time to progression. CASODEX Combination Study GroupP F Schellhammer, R Sharifi, N L Block, et al.Annals of Internal Medicine|August 6, 2008
Revising expectations from rapid HIV tests in the emergency departmentRochelle P Walensky, Christian Arbelaez, William M Reichmann, et al.Pageof 40